Tomáš Doležal

Cost of multiple sclerosis in the Czech Republic: The COMS study

Jana Blahová Dušánková, Tomáš Kalinčík, Tomáš Doležal et al. · Multiple Sclerosis Journal · 2011 · 40 citations

Pharmacy, Neurology, Pharmacoeconomics +17

Transferability of National Institute for Health and Clinical Excellence recommendations for pharmaceutical therapies in oncology to Central-Eastern European countries

Zoltán Kaló, Tomáš Doležal, Zoltán Vokó · European Journal of Cancer Care · 2012 · 38 citations

Pharmacy, Health Policy, Oncology +17

Role of health technology assessment in the process of implementation of the EU Transparency Directive: relevant experience from Central Eastern European countries

Katarzyna Kolasa, Zoltán Kaló, Vladimir Zah et al. · Expert Review of Pharmacoeconomics & Outcomes Research · 2012 · 33 citations

Law, Health Policy, Health Care Regulation +16

Work Productivity and Costs Related to Patients with Ankylosing Spondylitis, Rheumatoid Arthritis, and Psoriasis

K. Kruntoradova, Liliana Šedová, Jiří Štolfa et al. · Value in Health Regional Issues · 2014 · 23 citations

Medicine, Clinical Sciences, Internal Medicine +17

Access to novel cancer medicines in four countries in Central and Eastern Europe in relation to clinical benefit

Thomas Hofmarcher, P. Szilagyiova, Anna W Gustafsson et al. · ESMO Open · 2023 · 21 citations · Full text

Pharmacy, Oncology, Pharmaceutical Policy +10